US 5814331A
· Holen
· 1998
[cited by applicant]
US 5877023A
· Sautter et al.
· 1999
[cited by applicant]
US 6093557A
· Pui et al.
· 2000
[cited by applicant]
US 6764720B2
· Pui et al.
· 2004
[cited by applicant]
US 7667004B2
· Zhong et al.
· 2010
[cited by applicant]
US 7927874B2
· Ikemoto et al.
· 2011
[cited by applicant]
US 8101200B2
· Whitbourne et al.
· 2012
[cited by applicant]
US 8697359B1
· Zhang
· 2014
[cited by applicant]
US 8932814B2
· Cong et al.
· 2015
[cited by applicant]
US 9023649B2
· Mali et al.
· 2015
[cited by applicant]
US 9074199B1
· Chavez et al.
· 2015
[cited by applicant]
US 9079878B2
· Bagal et al.
· 2015
[cited by applicant]
US 20010006643A1
· Hope
· 2001
[cited by applicant]
US 20040033589A1
· O'Brien
· 2004
[cited by applicant]
US 20040213744A1
· Lulla et al.
· 2004
[cited by applicant]
US 20040242416A1
· Touitou
· 2004
[cited by applicant]
US 20090178934A1
· Jarvius et al.
· 2009
[cited by applicant]
US 20120135526A1
· Greenberg
· 2012
[cited by applicant]
US 20130053794A1
· Cadden et al.
· 2013
[cited by applicant]
US 20150044751A1
· Chiou et al.
· 2015
[cited by applicant]
US 20210054413A1
· Maguire et al.
· 2021
[cited by applicant]
JP H03251187A
· 1991
[cited by applicant]
JP H0662871A
· 1994
[cited by applicant]
JP H11322618A
· 1999
[cited by applicant]
JP 2004520020A
· 2004
[cited by applicant]
JP 2004536089A
· 2004
[cited by applicant]
JP 2018501812A
· 2018
[cited by applicant]
JP 2019503682A
· 2019
[cited by applicant]
JP 6779217B2
· 2020
[cited by applicant]
WO 9218164A1
· 1992
[cited by applicant]
WO 03000174A2
· 2003
[cited by applicant]
WO 2009130187A1
· 2009
[cited by applicant]
WO 2010117464A1
· 2010
[cited by applicant]
WO 2013058812A1
· 2013
[cited by applicant]
WO 2013061205A2
· 2013
[cited by applicant]
WO 2013142578A1
· 2013
[cited by applicant]
WO 2014033186A1
· 2014
[cited by applicant]
WO 2014159719A1
· 2014
[cited by applicant]
WO 2015088643A1
· 2015
[cited by applicant]
WO 2015071474
· 2015
[cited by applicant]
WO 2016065341A1
· 2016
[cited by applicant]
WO 2017115128A2
· 2017
[cited by applicant]
O'Dea, et al. (2017) “Vector-free intracellular delivery by reversible permeabilization”, PLOS One, 12(3): e0174779, 23 pages. (Year : 2017).
[cited by examiner]
Samuel et al. (2000) “Proline Inhibits Aggregation During Protein Refolding”, Protein Science, 9(2):344-352.
[cited by applicant]
Sather et al. (Sep. 30, 2015) “Efficient Modification of CCR5 in Primary Human Hematopoietic Cells Using a megaTAL Nuclease and AAV Donor Template”, Science Translational Medicine, 7(307):307ra156 (29 pages).
[cited by applicant]
Schumann et al. (Aug. 18, 2015) “Generation of Knock-in Primary Human T Cells using Cas9 Ribonucleoproteins”, Proceedings of the National Academy of Sciences, 112(33):10437-10442.
[cited by applicant]
Scott et al. (Aug. 3, 2011) “NoD: A Nucleolar Localization Sequence Detector for Eukaryotic and Viral Proteins”, BMC Bioinformatics, 12:317 (7 pages).
[cited by applicant]
Stengel et al. (Feb. 2, 2010) “Quaternary Dynamics and Plasticity Underlie Small Heat Shock Protein Chaperone Function”, Proceedings of the National Academy of Sciences, 107(5):2007-2012.
[cited by applicant]
Sung et al. (Nov. 2013) “Highly Efficient Gene Knockout in Mice and Zebrafish with RNA-guided Endonucleases”, Genome Research, 24(1):125-131.
[cited by applicant]
Wang et al. (Mar. 25, 2014) “Progressive Engineering of a Homing Endonuclease Genome Editing Reagent for the Murine X-linked Immunodeficiency Locus”, Nucleic Acids Research, 42(10):6463-6475.
[cited by applicant]
Whitley et al. (Apr. 1999) “Heat Shock Proteins: A Review of the Molecular Chaperones”, Journal of Vascular Surgery, 29(4):748-751.
[cited by applicant]
Wiedenheft et al. (Feb. 15, 2012) “RNA-Guided Genetic Silencing Systems in Bacteria and Archaea”, Nature, 482(7385):331-338.
[cited by applicant]
Xie et al. (1997) “Mechanism of the Stabilization of Ribonuclease A by Sorbitol: Preferential Hydration is Greater for the Denatured then for the Native Protein”, Protein Science, 6(1):211-221.
[cited by applicant]
Young et al. (Dec. 5, 2005) “Gelatin as a Delivery Vehicle for the Controlled Release of Bioactive Molecules”, Journal of Controlled Release, 109(1-3):256-274.
[cited by applicant]
Gaj et al. (Dec. 2016) “Genome-Editing Technologies: Principles and Applications”, Cold Spring Harbor Perspectives in Biology, 8(12):a023754.
[cited by applicant]
Gruber et al. (Jul. 1, 2008) “The Vienna RNA Websuite”, Nucleic Acids Research, 36:W70-W74.
[cited by applicant]
Elhissi et al. (2011) “Vibrating-Mesh Nebulization of Liposomes Generated Using an Ethanol-Based Proliposome Technology”, Journal of Liposome Research, 21(2):173-180.
[cited by applicant]
Gurtovenko et al. (Oct. 2010) “Defect-Mediated Trafficking across Cell Membranes: Insights from in Silico Modeling”, Chemical Reviews, 110(10):6077-6103.
[cited by applicant]
Gurtovenko et al. (2009) “Interaction of Ethanol with Biological Membranes: The Formation of Non-bilayer Structures within the Membrane Interior and their Significance”, The Journal of Physical Chemistry, Part B, 113(7)…
[cited by applicant]
Hapala (1997) “Breaking the Barrier: Methods for Reversible Permeabilization of Cellular Membranes”, Critical Reviews in Biotechnology, 17(2):105-122.
[cited by applicant]
Lemoine et al. (May 12, 2005) “Mechanism of Efficient Transfection of the Nasal Airway Epithelium by Hypotonic Shock”, Gene Therapy, 12(16):1275-1282.
[cited by applicant]
Medepalli et al. (Apr. 19, 2013) “A New Technique for Reversible Permeabilization of Live Cells for Intracellular Delivery of Quantum Dots”, Nanotechnology, 205101, 24(20):13 Pages.
[cited by applicant]
O'Dea et al. (Mar. 30, 2017) “Vector-Free Intracellular Delivery by Reversible Permeabilization”, PLOS One, e0174779, 12(3):23 Pages.
[cited by applicant]
Van De Ven et al. (2009) “Delivery of Optical Contrast Agents Using Triton-X100, Part 1: Reversible Permeabilization of Live Cells for Intracellular Labeling”, Journal of Biomedical Optics, 14(2):17 Pages.
[cited by applicant]
Van De Ven et al. (2009) “Delivery of Optical Contrast Agents Using Triton-X100, Part 2: Enhanced Mucosal Permeation for the Detection of Cancer Biomarkers”, Journal of Biomedical Optics, 14(2):22 Pages.
[cited by applicant]
Papapetrou et al. (Oct. 2005) “Genetic Modification of Hematopoietic Stem Cells with Nonviral Systems: Past Progress and Future Prospects”, Gene Therapy, 12:S118-S130.
[cited by applicant]
Beerli et al. (Dec. 8, 1998) “Toward Controlling Gene Expression at Will: Specific Regulation of the erbB-2/HER-2 Promoter by Using Polydactyl Zinc Finger Proteins Constructed from Modular Building Blocks”, Proceedings …
[cited by applicant]
Besser et al. (2009) “Modifying Interleukin-2 Concentrations During Culture Improves Function of T Cells for Adoptive Immunotherapy”, Cytotherapy, vol. 11, No. 2, 206-217.
[cited by applicant]
Bhakta et al. (2013) “Highly Active Zinc-finger Nucleases by Extended Modular Assembly”, Genome Research, 23:530-538.
[cited by applicant]
Boch et al. (2009) “Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors”, Science, 326(5959):1509-1512.
[cited by applicant]
Branzei et al. ( Apr. 2008) “Regulation of DNA Repair Throughout the Cell Cycle”, Nature Reviews Molecular Cell Biology, 9(4):297-308.
[cited by applicant]
Brocard et al. (Dec. 2006) “Peroxisome Targeting Signal 1: Is it Really a Simple Tripeptide?”, Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, 1763(12):1565-1573.
[cited by applicant]
Burger et al. (2016) “Maximizing Mutagenesis with Solubilized CRISPR-Cas9 Ribonucleoprotein Complexes”, Development, 143(11):2025-2037.
[cited by applicant]
Carr et al. (Dec. 2009) “Genome Engineering”, Nature Biotechnology, 27(12):1151-1162.
[cited by applicant]
Cermak et al. (Apr. 14, 2011) “Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting”, Nucleic Acids Research, 39(12):11 pages.
[cited by applicant]
Chen et al. (Dec. 2003) “Influence of Histidine on the Stability and Physical Properties of a Fully Human Antibody in Aqueous and Solid Forms”, Pharmaceutical Research, 20(12):1952-1960.
[cited by applicant]
Chevalier et al. (2001) “Homing Endonucleases: Structural and Functional Insight into the Catalysts of Intron/intein Mobility”, Nucleic Acids Research, 29(18):3757-3774.
[cited by applicant]
Cho et al. (Nov. 2013) “Heritable Gene Knockout in Caenorhabditis Elegans by Direct Injection of Cas9-sgRNA Ribonucleoproteins”, Genetics, 195(3):1177-1180.
[cited by applicant]
Cho et al. (Mar. 2013) “Targeted Genome Engineering in Human Cells with the Cas9 RNA-Guided Endonuclease”, Nature Biotechnology, 31(3):230-232.
[cited by applicant]
Christian et al. (Oct. 1, 2010) “Targeting DNA Double-Strand Breaks with TAL Effector Nucleases”, Genetics, 186(2):757-761.
[cited by applicant]
D'Amico et al. (Feb. 15, 2009) “A Nondetergent Sulfobetaine Improves Protein Unfolding Reversibility in Microcalorimetric Studies”, Analytical Biochemistry, 385(2):389-391.
[cited by applicant]
D'Astolfo et al. (Apr. 23, 2015) “Efficient Intracellular Delivery of Native Proteins”, Cell, 161(3):674-690.
[cited by applicant]
Deng et al. (2012) “Structural Basis for Sequence-specific Recognition of DNA by TAL Effectors”, Science, 335(6069):720-723.
[cited by applicant]
Dingwall et al. (Dec. 1991) “Nuclear Targeting Sequences—A Consensus?”, Trends in Biochemical Sciences, 16(12):478-481.
[cited by applicant]
Dwyer et al. (1999) “Molecular Simulation of the Effects of Alcohols on Peptide Structure”, Biopolymers, 49(7):635-645.
[cited by applicant]
Eyles et al. (Feb. 16, 2010) “Nature's Molecular Sponges: Small Heat Shock Proteins Grow into their Chaperone Roles”, Proceedings of the National Academy of Sciences, 107(7):2727-2728.
[cited by applicant]
Ferns et al. (Oct. 2011) “Protection Against Protein Aggregation by Alpha-crystalline as a Mechanism of Preconditioning”, Neurochemical Research, 37:244-252.
[cited by applicant]
Fineran et al. (Dec. 2012) “Memory of Viral Infections by CRISPR-Cas Adaptive Immune Systems: Acquisition of New Information”, Virology, 434(2):202-209.
[cited by applicant]
Han et al. (Aug. 14, 2015) “CRISPR-cas9 Delivery to Hard-to-transfect Cells Via Membrane Deformation”, Science Advances, Article No. e1500454, 1(7):9 pages.
[cited by applicant]
Han et al. (Oct. 2007) “Effects of Sugar Additives on Protein Stability of Recombinant Human Serum Albumin During Lyophilization and Storage”, Archives of Pharmacal Research, 30(9):1124-1131.
[cited by applicant]
Hsu et al. (Jun. 5, 2014) “Development and Applications of CRISPR-Cas9 for Genome Engineering”, Cell, 157(6):1262-1278.
[cited by applicant]
Ibarra et al. (Aug. 23, 2016) “Efficient Modification of the CCR5 Locus in Primary Human T Cells With megaTAL Nuclease Establishes HIV-1 Resistance”, Molecular Therapy—Nucleic Acids, Article No. e352, 5:10 pages.
[cited by applicant]
Jinek et al. (Aug. 17, 2012) “A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity”, Science, 337(6069):816-821.
[cited by applicant]
Kalderon et al. (Dec. 1984) “A Short Amino Acid Sequence Able to Specify Nuclear Location”, Biochemistry Division, National Institute for Medical Research, Cell, 39(3 Pt 2):499-509.
[cited by applicant]
Kerwin Bruce A. (Aug. 2008) “Polysorbates 20 and 80 used in the Formulation of Protein Biotherapeutics: Structure and Degradation Pathways”, 97(8):2924-2935.
[cited by applicant]
Kim et al. (2014) “Highly Efficient RNA-Guided Genome Editing in Human Cells via Delivery of Purified Cas9 Ribonucleoproteins”, Genome Research, 24(6):1012-1019.
[cited by applicant]
Li et al. (2015) “Challenges in CRISPR/CAS9 Delivery: Potential Roles of Nonviral Vectors”, Human Gene Therapy, 26(7):452-462.
[cited by applicant]
Liang et al. (Aug. 20, 2015) “Rapid and Highly Efficient Mammalian Cell Engineering via Cas9 Protein Transfection”, Journal of Biotechnology, 208:44-53.
[cited by applicant]
Lin et al. (Dec. 15, 2014) “Enhanced Homology-directed Human Genome Engineering by Controlled Timing of CRISPR/Cas9 Delivery”, eLife, 3:e04766:13 pages.
[cited by applicant]
Liu et al. (Oct. 2005) “Trehalose Differentially Inhibits Aggregation and Neurotoxicity of Beta-amyloid 40 and 42”, Neurobiology of Disease, 20(1):74-81.
[cited by applicant]
Makkerh et al. (Aug. 1996) “Comparative Mutagenesis of Nuclear Localization Signals Reveals the Importance of Neutral and Acidic Amino Acids”, Current Biology, 6(8):1025-1027.
[cited by applicant]
Martin et al. (May 1, 2017) “Efficient Vector-free Engineering of MSC with Retention of Cell Viability and Differentiation Potential”, Cytotherapy, 19(5):e23.
[cited by applicant]
Meaking et al. (Dec. 27, 1995) “Electroporation-induced Damage in Mammalian Cell DNA”, Biochimica et Biophysica Acta (BBA)—Gene Structure and Expression, 1264(3):357-362.
[cited by applicant]
Miller et al. (Feb. 2011) “A TALE Nuclease Architecture For Efficient Genome Editing”, Nature Biotechnology, 29(2): 143-148.
[cited by applicant]
Morimoto et al. (2008) “Proteotoxic Stress and Inducible Chaperone Networks in Neurodegenerative Disease and Aging”, Genes & Development, 22(11):1427-1438.
[cited by applicant]
Nakamura et al. (2000) “Codon Usage Tabulated from International DNA Sequence Database: Status for the Year 2000”, Nucleic Acid Research, 28(1):292 (1 page).
[cited by applicant]
O'Dea et al. (May 1, 2012) “Transfection of ‘Hard to Transfect’ Cells Using Electrospray: ‘Sprayfection’”, Physical Methods of Gene Delivery, 20(Suppl 1):S241 (1 page).
[cited by applicant]
Ohta et al., “Metabolomic Approach for Improving Ethanol Stress Tolerance in
[cited by applicant]
Omura Tsuneo (1998) “Mitochondria-Targeting Sequence, a Multi-Role Sorting Sequence Recognized at All Steps of Protein Import into Mitochondria”, The Journal of Biochemistry, 123(6):1010-1016.
[cited by applicant]
Osborn et al. (Mar. 2016) “Evaluation of TCR Gene Editing Achieved by TALENs, CRISPR/Cas9, and megaTAL Nucleases”, Molecular Therapy, 24(3):570-581.
[cited by applicant]
Park et al. (Aug. 2015) “Engineering Mesenchymal Stem Cells for Regenerative Medicine and Drug Delivery”, Methods, 84:3-16.
[cited by applicant]
Platts et al. (2015) “Controlling Protein Stability: Mechanisms Revealed using Formulations of Arginine, Glycine and Guanidinium HCL with Three Globular Proteins”, International Journal of Pharmaceutics, 486(1-2):131-13…
[cited by applicant]
Rapaport Doron (Nov. 2003) “Finding the Right Organelle. Targeting Signals in Mitochondrial Outer-Membrane Proteins”, EMBO Reports, 4(10):948-952.
[cited by applicant]
Reddy et al. (Nov. 2006) “Chaperone-like Activity and Hydrophobicity of a-Crystallin”, IUBMB Life, 58(11):632-641.
[cited by applicant]
Richter et al. (Oct. 20, 2010) “The Heat Shock Response: Life on the Verge of Death”, Molecular Cell, 40(2):253-266.
[cited by applicant]
Zuris et al. (Jan. 2015) “Efficient Delivery of Genome-Editing Proteins In Vitro and In Vivo”, Nature Biotechnology, 33(1):73-80.
[cited by applicant]